MetaCap

Phibro Animal Health (PAHC) vs Tyra Biosciences (TYRA)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

Tyra Biosciences (TYRA) has outperformed Phibro Animal Health (PAHC) over the past year, losing 4.7% versus a loss of 20.0%. Over five years, PAHC leads with a +59.4% price change compared with -15.7% for TYRA. Tyra Biosciences is the larger company by market cap ($1.39 billion vs $1.35 billion), about 1.0 times the size.

Phibro Animal Health pays a dividend yielding 1.44%, while Tyra Biosciences does not currently pay one.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

PAHC-20.03%TYRA-4.73%
+93%+28%-37%
Nov 21, 20251 yearNov 20, 2026
PAHC+52.78%TYRA-16.17%
+178%+44%-90%
Nov 15, 20215 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

PAHC versus TYRA key metrics
MetricPAHCTYRA
Share price$33.29$20.12
Market cap$1.35B$1.39B
1-day change-2.32%+1.98%
YTD return-10.89%-23.47%
1-year return-20.03%-4.73%
5-year return+59.43%-15.71%
P/E ratio (TTM)13.26—
Forward P/E8.58—
EPS (TTM)$2.51$-2.63
Dividend yield1.44%0.00%
Annual dividend$0.48$0.00
Revenue (latest FY)$1.52B—
Revenue growth (YoY)+17.12%—
Net income (latest FY)$99.72M$-119.95M
Gross margin33.76%—
Operating margin12.81%—
Net margin6.57%—
52-week high$60.08$40.65
52-week low$28.25$18.25
Distance from 52-week high-44.59%-50.50%
Analyst consensusholdstrong_buy
Avg. price target upside+41.18%+135.83%
Average volume228.99K852.56K
Shares outstanding21.11M69.08M
Employees2,60587
SectorHealth CareHealth Care
IndustryBiotechnology: Pharmaceutical PreparationsBiotechnology: Pharmaceutical Preparations

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • TYRA has outperformed PAHC by 15.3 percentage points over the past year.
  • Phibro Animal Health offers a meaningfully higher dividend yield (1.44% vs 0.00%).

About Phibro Animal Health

PAHC stock →

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Latin America and Canada, Europe, the Middle East, Africa, and the Asia Pacific. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products.

Health Care · Biotechnology: Pharmaceutical Preparations · 2,605 employees

About Tyra Biosciences

TYRA stock →

Tyra Biosciences, Inc., a clinical-stage biotechnology company, develops precision medicines for fibroblast growth factor receptor (FGFR) biology in the United States. The company offers SNÅP, a precision medicine platform that enables drug design through iterative molecular snapshots to predict genetic alterations for developing therapies targeting oncology and genetically defined conditions.

Health Care · Biotechnology: Pharmaceutical Preparations · 87 employees

PAHC vs TYRA FAQ

Which is bigger, Phibro Animal Health or Tyra Biosciences?

Tyra Biosciences (TYRA) is larger, with a market capitalization of $1.39B compared with $1.35B for Phibro Animal Health (PAHC).

Which stock has performed better over the past year, PAHC or TYRA?

TYRA returned -4.73% over the past 12 months, compared with -20.03% for PAHC (price return, excluding dividends). Past performance does not predict future results.

Which pays a higher dividend, Phibro Animal Health or Tyra Biosciences?

Phibro Animal Health pays a dividend yielding 1.44%, while Tyra Biosciences does not currently pay a regular dividend.

Are Phibro Animal Health and Tyra Biosciences in the same industry?

Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.

More comparisons